QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 244 filers reported holding QIAGEN NV in Q3 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81,971,931 | -11.3% | 2,023,372 | -1.6% | 0.03% | -3.3% |
| Q2 2023 | $92,379,631 | +17.3% | 2,056,848 | +19.0% | 0.03% | +7.1% |
| Q1 2023 | $78,764,865 | -23.7% | 1,728,893 | -16.1% | 0.03% | -30.0% |
| Q4 2022 | $103,239,288 | +36.9% | 2,060,006 | +14.8% | 0.04% | +37.9% |
| Q3 2022 | $75,435,000 | -13.7% | 1,794,095 | -4.0% | 0.03% | -6.5% |
| Q2 2022 | $87,377,000 | -4.1% | 1,868,701 | +1.6% | 0.03% | +10.7% |
| Q1 2022 | $91,109,000 | -9.3% | 1,840,032 | +2.1% | 0.03% | -6.7% |
| Q4 2021 | $100,421,000 | +1.9% | 1,802,644 | -5.1% | 0.03% | -6.2% |
| Q3 2021 | $98,575,000 | +5.6% | 1,899,483 | -1.6% | 0.03% | +3.2% |
| Q2 2021 | $93,363,000 | +6.7% | 1,931,322 | +7.1% | 0.03% | -6.1% |
| Q1 2021 | $87,519,000 | -7.5% | 1,803,990 | -0.8% | 0.03% | -10.8% |
| Q4 2020 | $94,591,000 | +2.0% | 1,819,290 | +1.9% | 0.04% | -9.8% |
| Q3 2020 | $92,754,000 | +15.6% | 1,784,593 | -4.2% | 0.04% | +5.1% |
| Q2 2020 | $80,215,000 | +0.6% | 1,863,696 | -6.0% | 0.04% | -17.0% |
| Q1 2020 | $79,774,000 | +9.7% | 1,982,271 | -7.1% | 0.05% | +34.3% |
| Q4 2019 | $72,717,000 | +13.1% | 2,133,453 | +0.6% | 0.04% | +2.9% |
| Q3 2019 | $64,298,000 | -21.4% | 2,120,710 | -4.4% | 0.03% | -22.7% |
| Q2 2019 | $81,847,000 | +9.0% | 2,218,239 | +8.6% | 0.04% | +2.3% |
| Q1 2019 | $75,119,000 | +58.1% | 2,042,019 | +29.9% | 0.04% | +16.2% |
| Q4 2018 | $47,500,000 | -27.0% | 1,572,596 | -17.6% | 0.04% | -21.3% |
| Q3 2018 | $65,108,000 | -5.6% | 1,908,290 | -9.1% | 0.05% | -11.3% |
| Q2 2018 | $68,973,000 | -3.9% | 2,100,279 | -5.5% | 0.05% | -3.6% |
| Q1 2018 | $71,803,000 | +41.7% | 2,221,377 | +19.4% | 0.06% | +48.6% |
| Q4 2017 | $50,683,000 | -3.6% | 1,860,740 | -2.6% | 0.04% | -7.5% |
| Q3 2017 | $52,573,000 | -6.1% | 1,909,956 | +0.8% | 0.04% | -11.1% |
| Q2 2017 | $55,998,000 | +235.5% | 1,894,296 | -0.1% | 0.04% | +221.4% |
| Q1 2017 | $16,690,000 | – | 1,896,813 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hardman Johnston Global Advisors LLC | 4,177,260 | $158,235,000 | 6.82% |
| Exane Asset Management | 522,037 | $19,742,931,000 | 6.18% |
| Tikvah Management LLC | 442,942 | $16,779,000 | 5.01% |
| Opus Point Partners Management, LLC | 31,620 | $1,198,000 | 2.86% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,600,672 | $98,144,000 | 2.79% |
| RTW INVESTMENTS, LP | 775,324 | $29,369,000 | 1.76% |
| SANDLER CAPITAL MANAGEMENT | 787,529 | $29,832,000 | 1.51% |
| FRIESS ASSOCIATES LLC | 531,900 | $20,148,000 | 1.40% |
| Sivik Global Healthcare LLC | 85,000 | $3,220,000 | 1.15% |
| Parametrica Management Ltd | 11,940 | $452,000 | 0.99% |